Innovating for future growth

2026 adjusted financial highlights*

Revenue
£m
(3.0%) organic constant currency (OCC)2
Operating profit (OCC)
£m
(1.6%)
Operating profit margin
%
(50) basis points
Operating profit margin (OCC)
%
+30 basis points
Net cash
£m
Dividend per share (proposed)
p
Basic earnings per share
p

*Adjusted items exclude the amortisation and impairment of acquired intangible assets, acquisition items, business reorganisation costs, other significant non-recurring items, and the mark-to-market movement of financial derivatives. References to year-on-year movements and margin percentages are shown at organic constant currency (OCC), prepared using prior year results translated at the current reporting year’s average exchange rates excluding disposals, and acquisitions are not included until the prior year includes a full year of performance. Comparators have been restated to reclassify NanoScience business as a discontinued operation. For full details see Financial Review and Financial Statements.

Quick links

At a
glance

Find out more

Reasons
to invest

Find out more

Our business
model

Find out more

Our
strategy

Find out more

Chair’s statement

Strategic actions beginning to unlock the full potential of Oxford Instruments

"The remarkable outcomes we have
achieved this year clearly reflect the
benefits of the actions we have taken
over the past two years"

NEIL CARSON

Chair

Read the Chair's statement

Chief Executive Officer’s review

Strong second half delivers good full-year performance

"We are making clear progress against our strategy
and remain well positioned in structurally
growing markets, supported by increased
investment in innovation, operational
excellence and our people."

RICHARD TYSON

Chief Executive Officer

Read the CEO Review

Operating divisions

Imaging
& Analysis

The Imaging & Analysis division develops and manufactures microscopes, scientific cameras, analytical instruments and software, with manufacturing bases in the UK (High Wycombe and Belfast), Europe (Aix-en-Provence, Ulm and Zurich) and the USA (Santa Barbara).

Orders
£317.3m
(2025: £318.6m)
Revenue
£314.7m
(2025: £330.5m)
Find out more

Advanced
Technologies

The Advanced Technologies division develops and manufactures compound semiconductor fabrication capital equipment (Severn Beach, UK), and X-ray tubes (Scotts Valley, USA).

Orders
£133.1m
(2025: £104.8m)
Revenue
£170.1m
(2025: £112.9m)
Find out more

Our strategy in action

State-of-the-art clean room at the heart of growth

With growing demand for our compound semiconductor solutions, particularly among manufacturing customers, we’re reaping the benefits of the significant investment made in our new facility at Severn Beach.

Find out more

Getting closer to our customers

A transformative shift in our approach to customer service is beginning to generate tangible positive outcomes for customers, and supporting the positioning of service as a driver of growth.

Find out more

Download centre

Download individual sections of the annual report